http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
위 정맥류 출혈에 대한 내시경적 정맥류 폐색술, 내시경적 정맥류 결찰술, 역행성 경정맥 위정맥류 폐색술 간의 치료효과 비교
김부성 ( Boo Sung Kim ),박재우 ( Park jae woo ),민슬기 ( Seul Ki Min ),김상균 ( Sang Gyune Kim ),김영석 ( Young Seok Kim ),배준용 ( Jun Yong Bae ),이종찬 ( Jong Chan Lee ),김홍수 ( Hong Soo Kim ),정승원 ( Soung Won Jeong ),장재영 대한소화기학회 2011 대한소화기학회지 Vol.57 No.5
Background/Aims: Endoscopic variceal obliteration (EVO), endoscopic variceal ligation (EVL), and balloon-occluded retrograde transvenous obliteration (BRTO) are used to manage gastric variceal bleeding. We compared the re-bleeding rates and survival times of these modalities. Methods: The study enrolled 103 patients with suspected gastric variceal bleeding between July 2001 and May 2009. For the management of gastric variceal bleeding, 52 patients underwent EVO; 36, EVL; and 15, BRTO. We evaluated their laboratory results and vital signs, and calculated the Child score, Child classification, and Model for End-stage Liver Disease score. Rebleeding was defined as new-onset hematemesis, hematochezia, melena, or endoscopically proven bleeding. Time-to-rebleeding and survival time were examined by Kaplan-Meyer analysis. A value of p<0.05 indicated statistical significance. Results: There were no significant differences in baseline characteristics among the three groups. The overall follow-up period averaged 65.13 months. During follow-up, rebleeding occurred in 17 patients (11 EVO, 5 EVL, and 1 BRTO). The times-to-rebleeding were 63.59, 75.79, and 51.41 months for EVO, EVL, and BRTO, respectively, and did not differ significantly (p=0.515). The median survival times were 77.42, 70.14, and 42.79 months, respectively, and also were not different significantly (p=0.978). Conclusions: There were no significant differences in the time-to-rebleeding or survival time among EVO, EVL, and BRTO. Further prospective, large-scale studies are needed. (Korean J Gastroenterol 2011;57:302-308)
김부성(Boo Sung Kim),정진우(Jin Wu Jeong),이창돈(Chang Don Lee),이성(Sung Lee),한남익(Nam Ik Han),김병기(Byong Ki Kim),홍설유(Seol Yun Hong),유석환(Suk Hwan Yoo) 대한소화기학회 1989 대한소화기학회지 Vol.21 No.1
Primary adenocarcinoma of the duodenum is an uncommon codition. It represents about 0.3% of all malignant neoplasms of the gastrointestinal tract and 25-45% of malignant neoplasms of the small intestine. The first documented case of the duodenal carcinoma was described by Hamburger 1746. Since then, only 694 cases have been presented in the literature up to the 1974. We have experienced a case of primary duodenal carcinoma, which was diagnosed by biopsies with gastrofibroscopic endoscopy. Therefore, we present here a case of duodenal carcinoma with a review of literture.
중합효소연쇄반응법 ( PCR ) 을 이용한 C 형 간염바이러스 RNA 의 검출
전기엽(Ki Youp Jeon),최영숙(Young Suck Choi),박영민(Yong Min Park),김부성(Boo Sung Kim) 대한내과학회 1994 대한내과학회지 Vol.47 No.3
Objectives: Hepatitis C virus (HCV) accounts for the occurrences of hepatocellular carcinoma, post-transfu- sion non-A non-B (NANR) hepatitis, sporadic NANB hepatitis and aggravates alcoholic liver disease. And we tred polymerase chain reaction (PCR) to evaluate hepatitis C viral infection. Methoda: We detected HCV RNA in the sera from patients with various liver diseases by PCR, to evaluate the replication and infectivity of HCU, And we compared HCV RNA positivity with anti-HCV positivity, Results: 1) In the 107 sporadic NANR liver diease patients, sixteen (15.0%) were anti HCV positive. In the 86 sporadic NANB liver disease patients, thirty-three (38,4%) were HCV-RNA positive. 2) In the 52 HBV-associated liver diasease patients, three (5.8%) were anti-HCV positive. In the 40 HBV- associated liver disease patients, three (12,5%) were HCV-RNA positive. 3) In the various liver diseases, positive rate of HCV- RNA by PCR was 2.1-2.6 times higher than that of anti-HCV. 4) In the total 13,488 blood donors for the three months of Red Cross Blood Center in Chonju, fourty-six (0.34%) were anti-HCV positive and sixteen (53%) among the thirty anti-HCV psitive sera were HCV-RNA positive. 5) Positive rate of anti-HCV of the blood donors, acute and chronic sporadic NANB hepatitis in Chonbuck area was much lower than that of Seoul area. But positive rate of HCV RNA by PCR was similar between two areas. Also positive rates of anti-HCV and HCV RNA in the NANB liver cirrhosis and NANB hepatodellular carcinoma were similar between two areas. Conclusion: By our results, it is suggested that the prevalence of C hepatitis may be underestimated by anti-HCV alone and so the detection of HCV-RNA by PCR is necessary for the true evaluation of HCV infection.
간동맥 화학색전술에 의한 간세포암종 크기 감소 이후 간절제술을 시행한 환자
민슬기 ( Seul Ki Min ),김상균 ( Sang Gyune Kim ),김영석 ( Young Seok Kim ),이세환 ( Sae Whan Lee ),정승원 ( Soung Won Jeong ),장재영 ( Jae Young Jang ),김홍수 ( Hong Soo Kim ),김부성 ( Boo Sung Kim ) 대한간암학회 2011 대한간암학회지 Vol.11 No.1
Hepatocellular carcinoma (HCC) is the third most common cancer in korean population. Surgical management is the mainstay of HCC. Surgical resection and liver transplantation shows the best outcomes in well-selected patients. But few patients are possible to benefit from surgical resection or liver transplantation. The majority of cases of HCC are unresectable, but there are no proven treatment modalities for these cases. In small number of articles showed the favorable result of adjuvant chemotherapy, and transcatheter arterial chemoembolization (TACE) for unresectable HCCs. But there are some drawbacks, such as small number of sample size and variablity of study design at each studies. Hereby we report a patients of HCC, who was performed hepatectomy after tumor down sizing with TACE.
스텐트 삽입과 항암요법 후 근치적 절제술을 시행했던 폐쇄성 국소 침윤 공장 선암
김형기 ( Hyung Ki Kim ),고봉민 ( Bong Min Ko ),박종규 ( Jong Kyu Park ),홍수진 ( Su Jin Hong ),문종호 ( Jong Ho Moon ),이준성 ( Joon Seong Lee ),이문성 ( Moon Sung Lee ),김부성 ( Boo Sung Kim ) 대한소화기학회 2010 대한소화기학회지 Vol.56 No.1
Small bowel adenocarcinoma is a relatively rare malignancy. In Korea, 13.1% of small bowel adenocarcinoma occurs in the jejunum. The absence of effective screening methods and relatively obscure symptoms contribute to the higher percentage of advanced cases at the time of diagnosis. Although curative resection is the mainstay of treatment, it is often impossible. Chemotherapy and radiotherapy have shown a disappointing treatment result for advanced staged small bowel adenocarcinoma. We report a 54-year-old woman with locally invasive jejunal cancer who underwent curative resection after stent insertion with enteroscopy and chemotherapy. (Korean J Gastroenterol 2010;56:54-58)
김인철(In Chul Kim),김부성(Boo Sung Kim),정진우(Jin Wu Jeong),김병기(Byung Kee Kim),이창돈(Chang Don Lee),조현미(Hyun Mi Cho),육근수(Kun soo Yook),김주철(Ju Cherl Kim),조기원(Ki Weon cho) 대한소화기학회 1989 대한소화기학회지 Vol.21 No.3
Primary Cancer of the duodenum is rare. The rarity and the non-specific symptoms of this cancer make the diagnosis difficult and are major factors contributing to its poor prognosis. As the prognosis of primary cancer of the duodenum, once metastasized, is poor, a greater awareness of the possibility of a duodenal cancer must accompany aggressive diagnostic and surgical procedures. We report our experience of a patient with primary adenocarcinoma of the duodenum with a brief review of literatures.
만성 신부전 환자 21 예에 대한 혈액투석 및 복막투석의 경험
최규보 ( Kyu Bo Choi ),정규원 ( Kyu Won Chung ),민병석 ( Byong Sok Min ),김부성 ( Boo Sung Kim ),김희백 ( Hei Paik Kim ),김신걸 ( Shin Gull Kim ),정준호 ( Joon Ho Chung ),고용복 ( Young Bock Ko ),방병기 ( Byong Ki Bang ) 대한내과학회 1970 대한내과학회지 Vol.13 No.3
This report summarizes the authors experience with 53 dialysis on 21 patients with chronic renal failure treated at St. Mary`s Hospital from Mar. 25, 1969 through Sept. 2, 1969: 42 hemodialysis using Kolff`s twin coil artificial kidney for average 6 hours